Page last updated: 2024-12-10

6-hydroxyluteolin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

6-hydroxyluteolin: isolated from Thymus carnosus Boiss. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

6-hydroxyluteolin : A pentahydroxyflavone that is luteolin with an additional hydroxy group at position 6. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

FloraRankFlora DefinitionFamilyFamily Definition
Thymusgenus[no description available]LamiaceaeThe mint plant family. They are characteristically aromatic, and many of them are cultivated for their oils. Most have square stems, opposite leaves, and two-lipped, open-mouthed, tubular corollas (united petals), with five-lobed, bell-like calyxes (united sepals).[MeSH]
Thymus carnosusspecies[no description available]LamiaceaeThe mint plant family. They are characteristically aromatic, and many of them are cultivated for their oils. Most have square stems, opposite leaves, and two-lipped, open-mouthed, tubular corollas (united petals), with five-lobed, bell-like calyxes (united sepals).[MeSH]

Cross-References

ID SourceID
PubMed CID5281642
CHEMBL ID464107
CHEBI ID2197
SCHEMBL ID1155724
MeSH IDM0161105

Synonyms (24)

Synonym
4h-1-benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-5,6,7-trihydroxy-
3',4',5,6,7-pentahydroxyflavone
2-(3,4-dihydroxyphenyl)-5,6,7-trihydroxy-4h-1-benzopyran-4-one
2-(3,4-dihydroxyphenyl)-5,6,7-trihydroxy-4h-chromen-4-one
CHEBI:2197 ,
18003-33-3
6-hydroxyluteolin
5,6,7,3',4'-pentahydroxyflavone
CHEMBL464107 ,
demethylpedalitin
LMPK12111229
unii-t1xt53489d
6-oh-luteolin
t1xt53489d ,
2-(3,4-dihydroxyphenyl)-5,6,7-trihydroxychromen-4-one
bdbm50412291
SCHEMBL1155724
flavone, 3',4',5,6,7-pentahydroxy-
nornepetin
nornepitin
6-hydroxyluteolol
DTXSID10170900
Q23055354
E87163
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
pentahydroxyflavoneA hydroxyflavone substituted by five hydroxy groups.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (1)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Aldo-keto reductase family 1 member B1Rattus norvegicus (Norway rat)IC50 (µMol)0.20420.00041.877310.0000AID342547
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (7)

Assay IDTitleYearJournalArticle
AID1176794Inhibition of biofilm formation in Staphylococcus aureus AH133 transformed with GFP assessed as reduction in recovery of CFU at 80 ug/disc after 24 hrs by confocal laser scanning microscopy2015Journal of natural products, Jan-23, Volume: 78, Issue:1
Teucrium polium phenylethanol and iridoid glycoside characterization and flavonoid inhibition of biofilm-forming Staphylococcus aureus.
AID1176792Inhibition of biofilm formation in Staphylococcus aureus AH133 transformed with GFP assessed as zone of inhibition at 10 to 20 ug/disc after 24 hrs by confocal laser scanning microscopy2015Journal of natural products, Jan-23, Volume: 78, Issue:1
Teucrium polium phenylethanol and iridoid glycoside characterization and flavonoid inhibition of biofilm-forming Staphylococcus aureus.
AID1176793Inhibition of biofilm formation in Staphylococcus aureus AH133 transformed with GFP assessed as zone of inhibition at 40 to 80 ug/disc after 24 hrs by confocal laser scanning microscopy2015Journal of natural products, Jan-23, Volume: 78, Issue:1
Teucrium polium phenylethanol and iridoid glycoside characterization and flavonoid inhibition of biofilm-forming Staphylococcus aureus.
AID619461Inhibition of dephosphorylated glycogen phosphorylase2011European journal of medicinal chemistry, Oct, Volume: 46, Issue:10
Synthesis and biological activity of novel tiliroside derivants.
AID400266Inhibition of rat fetal brain CDK5 assessed as phosphorylated histone H1 levels by immuno-precipitation2004Journal of natural products, Mar, Volume: 67, Issue:3
Effects of natural flavones and flavonols on the kinase activity of Cdk5.
AID342547Inhibition of rat lens aldose reductase2008Bioorganic & medicinal chemistry, Aug-01, Volume: 16, Issue:15
QSAR prediction of inhibition of aldose reductase for flavonoids.
AID1176791Inhibition of biofilm formation in Staphylococcus aureus AH133 transformed with GFP assessed as zone of inhibition at 16 mg/ml after 24 hrs by confocal laser scanning microscopy2015Journal of natural products, Jan-23, Volume: 78, Issue:1
Teucrium polium phenylethanol and iridoid glycoside characterization and flavonoid inhibition of biofilm-forming Staphylococcus aureus.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (8)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (12.50)18.7374
1990's0 (0.00)18.2507
2000's4 (50.00)29.6817
2010's3 (37.50)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.94

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.94 (24.57)
Research Supply Index2.30 (2.92)
Research Growth Index4.24 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.94)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other9 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]